Amesite (AMST) Stock Analysis & AI Equity Report

Software - Application USD Explore free reports

Amesite (AMST) overview

Amesite (AMST) stock analysis and AI equity research. For financial year 2026, Valuatum's model shows revenue of USD 0.4m and operating profit of USD -3.1m; the year-end share price was 1.33 USD and market capitalisation was USD 8.7m. Amesite is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Amesite's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 2.7mFY 2026
Share price1.33 USDFY 2026 year end
RevenueUSD 0.4mFY 2026
Operating profitUSD -3.1mFY 2026
Net earningsUSD -3.1mFY 2026
Market capitalisationUSD 8.7mFY 2026 year end

About Amesite

Amesite develops AI-powered applications for enterprises and professionals, with emphasis on post-acute healthcare. Its NurseMagic products provide documentation and workflow tools for individual nurses, caregivers, and healthcare businesses, while LynkMagic offers enterprise AI solutions for healthcare and related organizations. The company also operates Amesite Engage, an application serving professional, educational, and individual needs, though it is not currently dedicating resources to its growth.

Generate the Amesite report

Amesite is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Amesite and represent financial year 2026. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Amesite

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.